Bristol-Myers Squibb (BMY) cash on hand

Cash · fiscal 2025
$10.67B

Bristol-Myers Squibb (BMY) held cash of $10.67B at the end of fiscal 2025 (December 31, 2025). That is 1.7% lower than the $10.86B of fiscal 2024. Figures as of 18 Nov 2026, 02:51 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$10.67B
Change on fiscal 2024
−1.7%
Highest on record
$12.28Bfiscal 2023
Lowest on record
$9.25Bfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bristol-Myers Squibb cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $12.28B in fiscal 2023 and the lowest $9.25B in fiscal 2022.

History · 4 fiscal years

Cash by fiscal year

Bristol-Myers Squibb cash on hand, year by year

Bristol-Myers Squibb (BMY) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$10.67B 1.7% down
2024$10.86B 11.6% down
2023$12.28B 32.7% up
2022$9.25B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Bristol-Myers Squibb and comparable companies
CompanyCashFiscal year
Vertex Pharmaceuticals VRTX$6.61B2025
Medtronic MDT$9.22B2026
Bristol-Myers Squibb BMY$10.67B2025
Stryker SYK$4.10B2025
McKesson MCK$3.98B2026
Sanofi SNY€8.47B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BMY

Bristol-Myers Squibb, figure by figure

Bristol-Myers Squibb (BMY) overview: price, valuation and scorecardAll health care companies by market value

Bristol-Myers Squibb cash on hand: questions and answers

How much cash does Bristol-Myers Squibb have?

Bristol-Myers Squibb (BMY) held cash of $10.67B at the end of fiscal 2025 (December 31, 2025). That is 1.7% lower than the $10.86B of fiscal 2024.

What are the highest and lowest cash figures on record for Bristol-Myers Squibb?

Across the 4 fiscal years on record (2022–2025), the highest was $12.28B in fiscal 2023 and the lowest $9.25B in fiscal 2022.

How is Bristol-Myers Squibb's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bristol-Myers Squibb (BMY) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/BMY/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.